Singulair
Singulair is a prescription medication widely used to manage certain respiratory and allergic conditions. It works by targeting specific inflammatory pathways in the body to alleviate symptoms and improve quality of life for affected individuals.

Key Takeaways
- Singulair is a leukotriene receptor antagonist used to treat asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
- It works by blocking leukotrienes, which are chemicals that cause inflammation and narrowing of airways.
- Dosage varies by age and condition, and it is available in several forms for convenient administration.
- Common side effects are generally mild, but serious neuropsychiatric events are a known warning.
- Always consult a healthcare professional for proper diagnosis, prescription, and management of treatment.
What is Singulair and How It Works
Singulair is a medication known generically as montelukast. It belongs to a class of drugs called leukotriene receptor antagonists. These medications work by blocking the action of leukotrienes, which are naturally occurring chemicals in the body. Leukotrienes contribute to inflammation, swelling, and tightening of the airways in the lungs, as well as symptoms of allergic rhinitis.
Singulair specifically targets leukotriene D4 receptors in the airways. By blocking these receptors, Singulair helps to reduce the inflammation and bronchoconstriction (narrowing of the airways) that are characteristic of asthma. This action helps to prevent asthma attacks and improve breathing, making it easier for patients to manage their condition. It is important to note that Singulair is not a rescue medication for acute asthma attacks but rather a long-term control medication.
Singulair Uses and Dosage
Singulair is prescribed for several conditions, including the long-term treatment of asthma in adults and pediatric patients 12 months of age and older, prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older, and relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, as well as perennial allergic rhinitis in adults and pediatric patients 6 months of age and older. According to the World Health Organization (WHO), asthma affects an estimated 262 million people globally, highlighting the need for effective management strategies like Singulair.
Regarding Singulair dosage and administration, the medication is available in various forms: 10 mg film-coated tablets, 5 mg and 4 mg chewable tablets, and 4 mg oral granules. The dosage typically varies based on the patient’s age and the condition being treated. For adults and adolescents 15 years and older, the usual dose for asthma or allergic rhinitis is one 10 mg tablet daily in the evening. For younger children, specific dosages are prescribed:
- Children 6 to 14 years of age: one 5 mg chewable tablet daily in the evening.
- Children 2 to 5 years of age: one 4 mg chewable tablet or one 4 mg packet of oral granules daily in the evening.
- Children 6 months to 2 years of age (for perennial allergic rhinitis only): one 4 mg packet of oral granules daily in the evening.
It is crucial to follow the healthcare provider’s instructions precisely and not to adjust the dose without medical advice.
Singulair Side Effects and Warnings
Like all medications, Singulair can cause side effects, and patients should be aware of Singulair side effects and warnings. Common side effects are generally mild and may include headache, stomach pain, heartburn, dizziness, tiredness, cough, and rash. These often resolve as the body adjusts to the medication. However, more serious side effects, though less common, can occur.
A significant warning associated with Singulair involves neuropsychiatric events. These can include agitation, aggression, depression, sleep disturbances (such as insomnia and nightmares), tremors, hallucinations, and suicidal thoughts and behavior. The U.S. Food and Drug Administration (FDA) has issued warnings regarding these potential risks, advising healthcare professionals and patients to be vigilant for such changes. Patients or caregivers should report any mood or behavior changes to their doctor immediately. Singulair should not be abruptly stopped without consulting a healthcare provider, especially if it is being used for asthma management, as this could worsen the underlying condition.



















